John L. Bishop - Jul 17, 2023 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Director
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Jul 17, 2023
Transactions value $
-$477,602
Form type
4
Date filed
7/19/2023, 08:35 PM
Previous filing
Jun 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Options Exercise $63.7K +10K +30.19% $6.37 43.1K Jul 17, 2023 Direct F1
transaction VCYT Common Stock Sale -$300K -10K -23.19% $30.00 33.1K Jul 17, 2023 Direct F1, F2
transaction VCYT Common Stock Options Exercise $63.7K +10K +30.19% $6.37 43.1K Jul 18, 2023 Direct F1
transaction VCYT Common Stock Sale -$305K -10K -23.19% $30.50 33.1K Jul 18, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCYT Stock Option (right to buy) Options Exercise $0 -10K -28.57% $0.00 25K Jul 17, 2023 Common Stock 10K $6.37 Direct F1, F3
transaction VCYT Stock Option (right to buy) Options Exercise $0 -10K -40% $0.00 15K Jul 18, 2023 Common Stock 10K $6.37 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023.
F2 Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F3 The option is fully vested.